CPH Group's Annual General Meeting has approved all agenda items by a large majority.

The CPH Group AG with its Chemistry and Packaging divisions generated net sales of CHF 323.3 million in 2024. EBITDA for the year amounted to CHF 53.8 million, producing an EBITDA margin of 16.6%. After inclusion of the CHF -29.8 million net first-half result for the spun-off Paper Division, the net result for 2024 amounted to CHF 4.6 million. The net result for the year for the remaining business divisions totalled CHF 34.4 million.

The Board of Directors of CPH Group AG has appointed Dr. Alois Waldburg-Zeil to serve as the company’s new CEO and head of its Group Executive Board. He will assume his new duties on April 1, 2025. Dr. Waldburg-Zeil is presently head of the company’s Chemistry Division. He succeeds Peter Schildknecht, who served as CEO for the past 16 years.

The CPH Group has completed its acquisition of the LOG Pharma company with its production sites in Israel and Hungary. In doing so, the Group has taken a further step in its global expansion strategy in regions with high growth potential.

CPH Group AG's CEO Peter Schildknecht will step down from his role as CEO of CPH Group AG and Perlen Industrieholding AG (formerly known as CPH Chemie + Papier Holding AG) at the beginning of 2026 in order to devote more time to strategic tasks. CPH Group AG’s and Perlen Industrieholding AG's Board of Directors would like to thank him for his outstanding contribution to the Group's development over the past 16 years.

The Packaging Division of the CPH Group is to acquire the LOG Pharma company.

The Packaging Division of the CPH Group is to acquire the LOG Pharma company, which has production sites in Israel and Hungary. The purchase of this manufacturer of complementary packaging solutions for the pharmaceutical and medicine industry marks the next step in the CPH Group’s expansion strategy. In acquiring LOG Pharma, the CPH Group will also establish its own presence in the attractive Eastern European pharmaceutical packaging market.

At the 2024 Investors' Day, the CPH Group took an in-depth look at the Packaging Division.

The CPH Group with its remaining Chemistry and Packaging divisions reported net sales of CHF 176.9 million for the first half of 2024. EBITDA for the period amounted to CHF 30.2 million, giving an EBITDA margin of 17.1 %. The net result for the Group’s remaining divisions amounted to CHF 21.1 million. With results for the spun-off Paper Division included, the net result stood at CHF ‑ 8.7 million. The Group has confirmed its outlook for 2024.

Separation of paper business from chemistry and packaging activities of CPH Group AG successfully effected. Off-exchange trading in shares of the newly spun-off and newly founded Perlen Industrieholding AG begins today.

• Separation of paper business from chemistry and packaging activities successfully effected • Newly named CPH Group AG will seek further organic and non-organic growth • Off-exchange trading in shares of the newly spun-off and newly founded Perlen Industrieholding AG begins today

• The shareholders of CPH Chemie + Papier Holding AG have approved the creation of two separate companies, the stock exchange-listed CPH Group AG and the off-exchange Perlen Industrieholding AG. • Existing CPH shareholders will receive one registered share in the new Perlen Industrieholding AG for every CPH registered share they hold through the distribution of a dividend-in-kind which will be effected by 27 June 2024. • The first trading day for the shares of Perlen Industrieholding AG has been scheduled for 25 June 2024.

The shareholders of CPH Chemie + Papier Holding AG (CPH) voted at today’s Extraordinary General Meeting (EGM) in Perlen to approve the separation proposed in March 2024 of the company’s paper manufacturing business from its chemistry and packaging activities by 98,2 %.